ArticleACS medicinal chemistry letters2017

Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1.

Julian R Levell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.